Septerna (SEPN) EBIT (2023 - 2026)
Septerna (SEPN) recorded quarterly EBIT of -$13.3 million in Q1 2026, down 131.66% quarter-over-quarter from $42.0 million in Q4 2025, and up 48.67% on a YoY basis from -$8.9 million in Q1 2025.
Septerna (SEPN) EBIT (2023 - 2026) Analysis & Trends
Septerna's EBIT history runs 4 years deep, the most recent figure standing at -$13.3 million for Q1 2026.
- In Q1 2026, EBIT rose 48.67% year-over-year to -$13.3 million; the TTM figure through Mar 2026 stood at $2.3 million (up 102.57% YoY), while the FY2025 annual figure was -$10.3 million, up 87.3% from the prior year.
- EBIT was -$13.3 million for Q1 2026 at Septerna, down from $42.0 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $42.0 million in Q4 2025 to a low of -$29.0 million in Q2 2025.
- Historically, EBIT has averaged -$7.5 million across 4 years, with a median of -$15.5 million in 2024.
- The sharpest annual moves came in 2024 and 2025: EBIT plunged 172.03% in 2024, then jumped 269.97% in 2025.
- A 4-year view of EBIT shows it stood at $34.3 million in 2023, then sank by 172.03% to -$24.7 million in 2024, then surged by 269.97% to $42.0 million in 2025, then tumbled by 131.66% to -$13.3 million in 2026.
- The last three EBIT figures came in at -$13.3 million (Q1 2026), $42.0 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | -13.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.30 Mn |
| Dec 31, 2025 | 42.01 Mn |
| Sep 30, 2025 | 2.61 Mn |
| Jun 30, 2025 | -28.98 Mn |
| Mar 31, 2025 | -25.91 Mn |
| Dec 31, 2024 | -24.72 Mn |
| Sep 30, 2024 | -22.55 Mn |
| Jun 30, 2024 | -18.07 Mn |
| Mar 31, 2024 | -15.49 Mn |
| Dec 31, 2023 | 34.32 Mn |
| Sep 30, 2023 | -12.04 Mn |